26 Jan Outpatient Nirmatrelvir-Ritonavir and Remdesivir Utilization in Canada
Posted at 15:59h
in
Outpatient Nirmatrelvir-Ritonavir and Remdesivir Utilization in Canada
HC0069
Overview
Background
- Nirmatrelvir-ritonavir (Paxlovid) and remdesivir are two antiviral therapies indicated for the treatment of non-hospitalized adult patients with mild to moderate COVID-19.
Aims of the study
- The purpose of this study is to describe the use of Paxlovid and remdesivir in the outpatient setting across Canadian provinces for which data are readily available, and describe the characteristics of patients receiving these therapies.
- This project is a collaboration with ADTEC and INESSS.